isoxazoles has been researched along with Epithelial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, SC; Jeong, GO; Kim, JH; Kim, KH; Kwon, YW; Seo, EJ; Shin, SH; Suh, DS; Yoon, MS | 1 |
| Cao, L; Matei, D; Nakshatri, H; Petrache, I; Petrusca, DN; Satpathy, M | 1 |
2 other study(ies) available for isoxazoles and Epithelial Neoplasms
| Article | Year |
|---|---|
TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Topics: Butadienes; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Isoxazoles; Lysophospholipids; Neoplasms, Glandular and Epithelial; Nitriles; Ovarian Neoplasms; Propionates; Protein Stability; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins | 2013 |
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
Topics: Antineoplastic Agents; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Survival; Cisplatin; Female; GTP-Binding Proteins; Humans; Isoxazoles; Neoplasms, Glandular and Epithelial; NF-kappa B; Ovarian Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Signal Transduction; Transglutaminases; X-Linked Inhibitor of Apoptosis Protein | 2008 |